Actively Recruiting

Age: 18Years +
All Genders
NCT06282939

Optima Coil Performance in The Interventional Management of Intracranial Aneurysms Registry

Led by HCA Healthcare Research Institute · Updated on 2024-02-28

600

Participants Needed

1

Research Sites

213 weeks

Total Duration

On this page

Sponsors

H

HCA Healthcare Research Institute

Lead Sponsor

B

Balt USA

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a prospective, open-label, consecutive enrollment, multi-center, U.S. registry of patients with intracranial aneurysms who are treated with the Optima Coil System. The primary objective of this registry is to evaluate the safety and effectiveness of the OptimaTM Coil System, including the OptiMAX Coils, in the real-world treatment of intracranial aneurysms. Imaging will be analyzed by a designated core neuroimaging lab to assess procedural success and aneurysm occlusion rates. Intent to treat population total: 700 patients 600 patients, up to 100 screen failures.

CONDITIONS

Official Title

Optima Coil Performance in The Interventional Management of Intracranial Aneurysms Registry

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients must be treated according to the FDA-cleared indication for the Optima Coil System
  • Patient age 18 years or older
  • A previously untreated, saccular intracranial aneurysm measuring 24 mm or less suitable for coil embolization
  • At least 75% of implanted coils must be from the Optima Coil System
  • Patient or legally authorized representative provided verbal consent and received IRB-approved consent information
  • Patient willing to comply with study follow-up requirements
  • Hunt & Hess classification of 4 or less for ruptured aneurysms, if applicable
Not Eligible

You will not qualify if you...

  • Life expectancy less than 1 year
  • Previously enrolled in the OPTIMA Registry
  • Known multiple intracranial aneurysms requiring treatment during the index procedure or follow-up, apart from the targeted aneurysm
  • Unwilling or unable to comply with protocol follow-up schedule or deemed unsuitable by investigator
  • Participation in another interventional clinical study that could interfere with this registry
  • Pre-planned staged procedures on unruptured target aneurysms

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Med City Plano

Plano, Texas, United States, 75075

Actively Recruiting

Loading map...

Research Team

A

Allison Kiser

CONTACT

G

Gina Remington

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here